Fig. 2From: Significance of the urokinase-type plasminogen activator and its receptor in the progression of focal segmental glomerulosclerosis in clinical and mouse modelsDeficiency of the urokinase-type plasminogen activator (uPA) accelerated the decrease of renal functions in a focal segmental glomerulosclerosis (FSGS) mouse model. a Proteinuria was expressed as total protein (mg/ml) over creatinine (mg/dl), and (b) plasma albumin was determined in wild-type (WT) and uPA−/− groups during the course of the experiment until 4 weeks after Adriamycin treatment. # p < 0.05 vs. week 0 (W0); *p < 0.05 vs. the WTBack to article page